Zeo ScientifiX Files 8-K

Ticker: ZEOX · Form: 8-K · Filed: Feb 11, 2025 · CIK: 1557376

Sentiment: neutral

Topics: regulatory-filing, 8-K

TL;DR

Zeo ScientifiX filed an 8-K, but it's mostly boilerplate with no juicy details yet.

AI Summary

Zeo ScientifiX, Inc. filed an 8-K on February 11, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Organicell Regenerative Medicine, Inc., is incorporated in Nevada and headquartered in Davie, Florida. This filing does not contain specific financial details or event descriptions beyond the standard reporting categories.

Why It Matters

This 8-K filing indicates Zeo ScientifiX, Inc. is making a regulatory submission, which could relate to financial reporting or other material events, but lacks specific details.

Risk Assessment

Risk Level: low — The filing is a standard 8-K without specific negative or positive disclosures, making the immediate risk level low.

Key Players & Entities

FAQ

What specific "Other Events" are being reported by Zeo ScientifiX, Inc. in this 8-K filing?

The provided text for the 8-K filing lists "Other Events" as an item information category but does not specify the nature of these events.

What is the significance of the "Financial Statements and Exhibits" being reported?

The filing indicates that financial statements and exhibits are part of the report, but the specific content or details of these documents are not elaborated upon in the provided text.

When was Zeo ScientifiX, Inc. previously known by another name?

Zeo ScientifiX, Inc. was formerly known as Organicell Regenerative Medicine, Inc., with a date of name change on June 25, 2018.

What is the business address of Zeo ScientifiX, Inc.?

The business address for Zeo ScientifiX, Inc. is 3321 College Avenue, Suite 246, Davie, Florida 33314.

What is the Commission File Number for Zeo ScientifiX, Inc.?

The Commission File Number for Zeo ScientifiX, Inc. is 000-55008.

Filing Stats: 456 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2025-02-11 08:45:19

Filing Documents

01 Other Events

Item 8.01 Other Events. On February 11, 2025, ZEO issued a press release providing a business update to stockholders and the investment community. A copy of the press release is included as Exhibit 99.1 to this Report.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated February 11, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: February 11, 2025 ZEO SCIENTIFIX, INC. By: /s/ Ian T. Bothwell Ian T. Bothwell Interim Chief Executive Officer and Chief Financial Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing